Insight & Intelligence

More »

May 15, Vol. 31, No. 10

  • Feature Articles

    • Screening Innovations Proliferate
    • Vicki Glaser
    • Screening technologies to advance drug discovery took center stage at the SBS meeting in Orlando at the end of March Key themes emerging from the scientific sessions and evident in the new technologies and products on display in the exhibit hall ... more »
    • SBS Conference Features Diverse New Product Rang...
    • The SBS meeting marked the US launch of Reinnervate’s alvetex® cell culture scaffold for 3-D in vitro cell growth Initially marketed in Europe in a 12-well plate format, alvetex is now available as 6-well and 12-well inserts It is supplied ... more »
    • Biosimilars Proceed with Caution from Starting G...
    • Angelo DePalma
    • Biosimilars were briefly (albeit unofficially) known as biogenerics, then follow-on biologics, before the current nomenclature was adopted The US FDA website defines biosimilars as “biological prescription drugs that are demonstrated to be ‘highly similar’ (biosimilar) to or ‘interchangeable’ with an ... more »
    • GEN's 30th Anniversary: Biogen Idec
    • During the early days of the biotechnology industry, there were several bellwether companies that analysts and other industry observers kept an eye on to get a sense of the biobusiness world’s health and potential Genentech, Amgen, Cetus, Centocor, and Genzyme ... more »
    • Mass Spec Makes Its Way into the Clinic
    • Catherine Shaffer
    • A significant shift in attitudes toward real-world use of mass spec in clinical settings was evident at this year’s meeting of The Association for Mass Spectrometry Applications to the Clinical Lab Scientists at the San Diego conference agreed that implementing ... more »
    • CROs Adapt to Meet Changing Paradigms
    • Ellyn Kerr
    • In its goal to advance safe, effective, and profitable drugs to market, the pharmaceutical industry has long acknowledged contract research as an essential resource But as several CROs discussed at Select Biosciences’ recent “Pharma Outsourcing Congress”, the CRO-pharma relationship has ... more »
    • Synthetic Bio Builds from the Bottom Up
    • Kate Marusina
    • The philosophical theory of reductionism pursues the idea that biological systems are most fruitfully investigated at the lowest possible, most fundamental level For many years, philosophy of science concerned itself with whether it is adequate to analyze a system by ... more »